# EDGAR Filing Document

**Accession Number:** 0001563665
**File Stem:** 0001437749-25-021097
**Filing Date:** 2025-6
**Character Count:** 8656
**Document Hash:** 9a7a176dd8b289088675a8ef0cf2febd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-021097.hdr.sgml**: 20250624

**ACCESSION NUMBER**: 0001437749-25-021097

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250620

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250624

**DATE AS OF CHANGE**: 20250624

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Harvard Apparatus Regenerative Technology, Inc.
- **CENTRAL INDEX KEY:** 0001563665
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 455210462
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35853
- **FILM NUMBER:** 251067058

**BUSINESS ADDRESS:**
- **STREET 1:** 84 OCTOBER HILL ROAD
- **STREET 2:** SUITE 11
- **CITY:** HOLLISTON
- **STATE:** MA
- **ZIP:** 01746
- **BUSINESS PHONE:** (774) 233-7300

**MAIL ADDRESS:**
- **STREET 1:** 84 OCTOBER HILL ROAD
- **STREET 2:** SUITE 11
- **CITY:** HOLLISTON
- **STATE:** MA
- **ZIP:** 01746

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Biostage, Inc.
- **DATE OF NAME CHANGE:** 20160331

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Harvard Apparatus Regenerative Technology, Inc.
- **DATE OF NAME CHANGE:** 20121204

?xml version='1.0' encoding='ASCII'? hrgn20250623_8k.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): June 20, 2025

**HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-35853** | **45-5210462** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **84 October Hill Road, Suite 11, Holliston, MA**  | **01746** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(774) 233-7300**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07** | **Submission of Matters to a Vote of Security Holders.**  |

---

On June 20, 2025, Harvard Apparatus Regenerative Technology, Inc. (the "<u>Company</u>") held its 2025 Annual Meeting of Stockholders (the "<u>Annual Meeting</u>"). At the Annual Meeting, the Company's stockholders voted on the following proposals: (i) the election of two Director Nominees as Class III Directors, each nominated by the Board of Directors of the Company for a three-year term, such term to continue until the annual meeting of stockholders in 2028 and until such Director's successor is duly elected and qualified or until their earlier resignation or removal, (ii) the ratification of the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2025, (iii) an amendment to the Corporation's amended and restated certificate of incorporation (the "Charter") to eliminate the classification of directors (the "<u>Declassification Amendment</u>"), (iv) an amendment to each of the: (A) Corporation's Charter and (B) Third Amended and Restated Bylaws, to permit special stockholder meetings to be called by holders of at least 35% of the Company's voting power ("<u>Meeting Amendment</u>"), (v) to approve an amendment to the Charter to effect a reverse split of our outstanding common stock, with the final decision of whether to proceed with the reverse stock split and the exact ratio and timing of the reverse split to be determined by our Board of Directors of the Company, and (vi) the non-binding approval of the compensation of the Company's named executive officers. The voting results for the matters submitted to a stockholder vote at the Annual Meeting are reported below.

***Proposal 1 - Election of Directors***

On such election of directors proposal, each of Jason Chen and Herman Sanchez were elected as Class III Directors, each for a three-year term, such term to continue until the annual meeting of stockholders in 2028 and until such director's successor is duly elected and qualified or until their earlier resignation or removal. Due to the plurality election, votes could only be cast in favor of or withheld from the nominee and thus votes against were not applicable. The results of the election were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Votes For** | **Votes Withheld** | **Broker Non-Votes** |
| Jason Chen | 12,657,458 | 833,485 | 948,616 |
| Herman Sanchez | 8,320,261 | 5,170,682 | 948,616 |

---

***Proposal 2*** – ***Ratification of the appointment of CBIZ CPAs P.C. as the Company***'***s independent registered public accounting firm for the fiscal year ending December 31, 2025***

The ratification of the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm was approved as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Votes For** | **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
|  | 14,395,092 | 28,247 | 16,220 | 0 |

---

***Proposal 3*** – ***The Declassification Amendment***

The Declassification Amendment was approved as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Votes For** | **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
|  | 13,455,304 | 31,277 | 4,362 | 948,616 |

---

***Proposal 4***– ***Meeting Amendment***

The Meeting Amendment was approved as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Votes For** | **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
|  | 13,454,161 | 29,751 | 7,031 | 948,616 |

---

***Proposal 5*** – ***Amendment to the Charter to effect a reverse split of our outstanding common stock***

The amendment to the Charter to effect a reverse split of our outstanding common stock was approved as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Votes For** | **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
|  | 14,318,702 | 88,435 | 32,422 | 0 |

---

***Proposal 6***– ***Approval, by Non-Binding Advisory Vote, of the Compensation of the Company***'***s Named Executive Officers***

The compensation of the Company's named executive officers was approved, by a non-binding advisory vote, as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Votes For** | **Votes For** | **Votes Against** | **Votes Abstained** | **Broker Non-Votes** |
|  | 13,421,257 | 63,730 | 5,956 | 948,616 |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | **HARVARD APPARATUS** <br> **REGENERATIVE TECHNOLOGY, INC.** |
| <br>**June 24, 2025** | (Registrant)<br>***/s/ Joseph Damasio*** |
| (Date) | Joseph Damasio |
|  | *Chief Financial Officer* |

---